Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study Meeting Abstract

  

Authors:	Presley, C.; Owen, D. H.; Nicholas, A.; Hilz, S.; Oezkan, F.; Chaft, J. E.; Toloza, E. M.; Haura, E. B.; Patterson, A.; Waqar, S. N.; Bunn, P.; Johnson, B. E.; Kris, M. G.; Lee, J. M.; Kwiatkowski, D. J.; Wistuba, I. I.; Schulze, K.; Johnson, A.; Rusch, V. W.; Carbone, D. P.
Abstract Title:	Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study
Meeting Title:	2023 World Conference on Lung Cancer (IASLC-WCLC)
Journal Title:	Journal of Thoracic Oncology
Volume:	18
Issue:	11 Suppl.
Meeting Dates:	2023 Sep 9-11
Meeting Location:	Singapore
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2023-11-01
Start Page:	S275
End Page:	S276
Language:	English
DOI:	10.1016/j.jtho.2023.09.470
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=173323064&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: P1.25-16 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/211084